Supernus to Participate in the TD Cowen 45th Annual Health Care Conference

ROCKVILLE, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the TD Cowen 45^th Annual Health Care Conference on Monday, March 3, 2025, at 11:10 a.m. ET in Boston, Mass.